Service & Technologies
Discover the cutting-edge services and technologies offered by the PDXGhent Core Facility. Explore how we can support your research with profound expertise tailored to your needs.
“The best way to predict the future is to create it.” – Peter Drucker
Preclinical models are crucial for advancing cancer research, from understanding disease biology and detecting biomarkers to developing innovative treatments. However, many novel therapies have failed early in clinical trials due to ineffective preclinical models.
The urgent need for more predictive models has led to the rise of patient-derived xenografts (PDX), which offer superior clinical relevance, reliability in drug screening, and preservation of tumor diversity.
Introducing the PDXGhent Core, your ultimate partner in streamlining cancer research. We centralize coordination to make workflows more efficient and cost-effective, supported by our expert team. From grant writing and budget calculations to experimental execution and analysis, we provide comprehensive technical and administrative support. Our PDX collection offers a diverse range of entities to enhance your research. By fostering stronger interactions and driving top-tier research, we’re here to propel your work to new heights. Let’s advance cancer research together with precision and excellence.
Contact: PDXGhentcore@ugent.be
Keywords: Cancer Research, pre-clinical modelling, mice modelling, Patient-Derived Xenografting, PDX, Gent, Ghent, core facility
